Literature DB >> 33099744

Epigenetic Blockade of Hippocampal SOD2 Via DNMT3b-Mediated DNA Methylation: Implications in Mild Traumatic Brain Injury-Induced Persistent Oxidative Damage.

Nagalakshmi Balasubramanian1, Sneha Sagarkar1,2, Amit G Choudhary3, Dadasaheb M Kokare3, Amul J Sakharkar4.   

Abstract

The recurrent events of mild trauma exacerbate the vulnerability for post-traumatic stress disorder; however, the underlying molecular mechanisms are scarcely known. The repeated mild traumatic brain injury (rMTBI) perturbs redox homeostasis which is primarily managed by superoxide dismutase 2 (SOD2). The current study investigates the role of DNA methylation in SOD2 gene regulation and its involvement in rMTBI-induced persistent neuropathology inflicted by weight drop injury paradigm. The oxidative damage, neurodegenerative indicators, and SOD2 function and its regulation in the hippocampus were analyzed after 48 h and 30 days of rMTBI. The temporal and episodic increase in ROS levels (oxidative stress) heightened 8-hydroxyguanosine levels indicating oxidative damage after rMTBI that was concomitant with decline in SOD2 function. In parallel, occupancy of DNMT3b at SOD2 promoter was higher post 30 days of the first episode of rMTBI causing hypermethylation at SOD2 promoter. This epigenetic silencing of SOD2 promoter was sustained after the second episode of rMTBI causing permanent blockade in SOD2 response. The resultant oxidative stress further culminated into the increasing number of degenerating neurons. The treatment with 5-azacytidine, a pan DNMT inhibitor, normalized DNA methylation levels and revived SOD2 function after the second episode of rMTBI. The release of blockade in SOD2 expression by DNMT inhibition also normalized the post-traumatic oxidative consequences and relieved the neurodegeneration and deficits in learning and memory as measured by novel object recognition test. In conclusion, DNMT3b-mediated DNA methylation plays a critical role in SOD2 gene regulation in the hippocampus, and the perturbations therein post rMTBI are detrimental to redox homeostasis manifesting into neurological consequences.

Entities:  

Keywords:  DNA methylation; Hippocampus; Mild traumatic brain injury; Neurodegeneration; Superoxide dismutase 2

Year:  2020        PMID: 33099744     DOI: 10.1007/s12035-020-02166-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  53 in total

1.  Repeated mild lateral fluid percussion brain injury in the rat causes cumulative long-term behavioral impairments, neuroinflammation, and cortical loss in an animal model of repeated concussion.

Authors:  Sandy R Shultz; Feng Bao; Vanessa Omana; Charlotte Chiu; Arthur Brown; Donald Peter Cain
Journal:  J Neurotrauma       Date:  2011-11-08       Impact factor: 5.269

2.  Neuropsychological performance following a history of multiple self-reported concussions: a meta-analysis.

Authors:  Heather G Belanger; Eric Spiegel; Rodney D Vanderploeg
Journal:  J Int Neuropsychol Soc       Date:  2009-12-11       Impact factor: 2.892

3.  Repeated mild traumatic brain injury causes chronic neuroinflammation, changes in hippocampal synaptic plasticity, and associated cognitive deficits.

Authors:  Stephanie L Aungst; Shruti V Kabadi; Scott M Thompson; Bogdan A Stoica; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-23       Impact factor: 6.200

4.  Minimal traumatic brain injury causes persistent changes in DNA methylation at BDNF gene promoters in rat amygdala: A possible role in anxiety-like behaviors.

Authors:  Sneha Sagarkar; Tanmayi Bhamburkar; Gajanan Shelkar; Amit Choudhary; Dadasaheb M Kokare; Amul J Sakharkar
Journal:  Neurobiol Dis       Date:  2017-06-27       Impact factor: 5.996

5.  Sports-related brain injury in the general population: an epidemiological study.

Authors:  Alice Theadom; Nicola J Starkey; Tony Dowell; Patria A Hume; Michael Kahan; Kathryn McPherson; Valery Feigin
Journal:  J Sci Med Sport       Date:  2014-02-09       Impact factor: 4.319

6.  Military- and sports-related mild traumatic brain injury: clinical presentation, management, and long-term consequences.

Authors:  Elaine R Peskind; David Brody; Ibolja Cernak; Ann McKee; Robert L Ruff
Journal:  J Clin Psychiatry       Date:  2013-02       Impact factor: 4.384

7.  Neuropsychological outcomes of mild traumatic brain injury, post-traumatic stress disorder and depression in Iraq-deployed US Army soldiers.

Authors:  Jennifer J Vasterling; Kevin Brailey; Susan P Proctor; Robert Kane; Timothy Heeren; Molly Franz
Journal:  Br J Psychiatry       Date:  2012-06-28       Impact factor: 9.319

8.  Repeated mild traumatic brain injury causes persistent changes in histone deacetylase function in hippocampus: Implications in learning and memory deficits in rats.

Authors:  Sneha Sagarkar; Nagalakshmi Balasubramanian; Shruti Mishra; Amit G Choudhary; Dadasaheb M Kokare; Amul J Sakharkar
Journal:  Brain Res       Date:  2019-01-18       Impact factor: 3.252

9.  Repeated mild traumatic brain injury: mechanisms of cerebral vulnerability.

Authors:  Mayumi L Prins; Daya Alexander; Christopher C Giza; David A Hovda
Journal:  J Neurotrauma       Date:  2013-01-01       Impact factor: 5.269

10.  Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players.

Authors:  Helen Ling; Huw R Morris; James W Neal; Andrew J Lees; John Hardy; Janice L Holton; Tamas Revesz; David D R Williams
Journal:  Acta Neuropathol       Date:  2017-02-15       Impact factor: 17.088

View more
  2 in total

1.  Repeated ethanol exposure and withdrawal alters ACE2 expression in discrete brain regions: Implications for SARS-CoV-2 infection.

Authors:  Nagalakshmi Balasubramanian; Thomas D James; Selvakumar Govindhasamy Pushpavathi; Catherine A Marcinkiewcz
Journal:  bioRxiv       Date:  2022-03-29

Review 2.  Roles of physical exercise in neurodegeneration: reversal of epigenetic clock.

Authors:  Miao Xu; JiaYi Zhu; Xian-Dong Liu; Ming-Ying Luo; Nan-Jie Xu
Journal:  Transl Neurodegener       Date:  2021-08-13       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.